PEAK6
TEVA icon

PEAK6’s Teva Pharmaceuticals TEVA Stock Holding History

PEAK6’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Buy
+384
New +$12.8K ﹤0.01% 2544
2025
Q4 		– Sell
-4,763
Closed -$117K – 3356
2025
Q3 		$96.2K Sell
4,763
-4,237
-47% -$74.4K ﹤0.01% 2614
2025
Q2 		$151K Buy
+9,000
New +$145K ﹤0.01% 2537

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

PEAK6's TEVA Position: Q2 2026 in Review

PEAK6 opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 384 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #2544 among its holdings. This is a return to the name: PEAK6 previously reported a position in TEVA as recently as Q3 2025.

PEAK6 first reported a position in TEVA in Q2 2025 and has held it in 3 quarters since. The position peaked at $151K in Q2 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • PEAK6 held 384 shares of Teva Pharmaceuticals worth $13K as of Q2 2026.
  • Teva Pharmaceuticals was a new PEAK6 position in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2544 holding.
  • PEAK6 first reported a position in Teva Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • PEAK6's Teva Pharmaceuticals position peaked at $151K in Q2 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.